Yifan Xinfu Pharmaceutical Co Ltd (002019) — Cash Flow-to-Debt Ratio
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥40.18 Million could theoretically repay 0% of its total liabilities (CN¥4.40 Billion) in one year. See 002019 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yifan Xinfu Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Yifan Xinfu Pharmaceutical Co Ltd across 23 annual periods. Also explore how fast is Yifan Xinfu Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Yifan Xinfu Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Yifan Xinfu Pharmaceutical Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥458.37 Million | CN¥4.13 Billion | ▼ -33.2% |
| 2024 | 0.17x | CN¥640.73 Million | CN¥3.86 Billion | ▲ +54.5% |
| 2023 | 0.11x | CN¥348.58 Million | CN¥3.24 Billion | ▼ -22.7% |
| 2022 | 0.14x | CN¥472.07 Million | CN¥3.40 Billion | ▲ +56.4% |
| 2021 | 0.09x | CN¥301.23 Million | CN¥3.39 Billion | ▼ -76.0% |
| 2020 | 0.37x | CN¥1.11 Billion | CN¥2.99 Billion | ▲ +28.4% |
| 2019 | 0.29x | CN¥937.24 Million | CN¥3.24 Billion | ▼ -28.8% |
| 2018 | 0.41x | CN¥1.17 Billion | CN¥2.89 Billion | ▼ -28.9% |
| 2017 | 0.57x | CN¥1.13 Billion | CN¥1.99 Billion | ▲ +105.5% |
| 2016 | 0.28x | CN¥855.85 Million | CN¥3.08 Billion | ▲ +15.1% |
| 2015 | 0.24x | CN¥401.96 Million | CN¥1.67 Billion | ▲ +36.6% |
| 2014 | 0.18x | CN¥139.74 Million | CN¥791.21 Million | ▲ +48.3% |
| 2013 | 0.12x | CN¥34.32 Million | CN¥288.20 Million | ▲ +131.4% |
| 2012 | 0.05x | CN¥29.88 Million | CN¥580.73 Million | ▲ +167.9% |
| 2011 | -0.08x | CN¥-52.82 Million | CN¥696.73 Million | ▼ -11.6% |
| 2010 | -0.07x | CN¥-33.82 Million | CN¥497.79 Million | ▼ -126.4% |
| 2009 | 0.26x | CN¥58.61 Million | CN¥227.31 Million | ▼ -11.7% |
| 2008 | 0.29x | CN¥83.31 Million | CN¥285.39 Million | ▼ -60.6% |
| 2007 | 0.74x | CN¥248.71 Million | CN¥335.87 Million | ▲ +508.2% |
| 2006 | 0.12x | CN¥32.62 Million | CN¥267.92 Million | ▼ -1.1% |
| 2005 | 0.12x | CN¥24.12 Million | CN¥196.02 Million | ▼ -82.1% |
| 2004 | 0.69x | CN¥33.59 Million | CN¥48.72 Million | ▲ +470.5% |
| 2003 | 0.12x | CN¥12.65 Million | CN¥104.73 Million | — |